Whittier Trust Co. decreased its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 4.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,555 shares of the pharmacy operator’s stock after selling 702 shares during the quarter. Whittier Trust Co.’s holdings in Walgreens Boots Alliance were worth $984,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares in the last quarter. Westside Investment Management Inc. boosted its position in Walgreens Boots Alliance by 10.4% during the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares in the last quarter. Zions Bancorporation boosted its position in Walgreens Boots Alliance by 983.3% during the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 1,239 shares in the last quarter. IHT Wealth Management LLC raised its stake in Walgreens Boots Alliance by 46.3% in the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after buying an additional 2,199 shares during the last quarter. Finally, Bristlecone Advisors LLC purchased a new stake in Walgreens Boots Alliance in the third quarter valued at about $135,000. 61.57% of the stock is currently owned by institutional investors and hedge funds.
Walgreens Boots Alliance Inc (WBA) opened at $68.49 on Thursday. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a 12-month low of $63.82 and a 12-month high of $88.00. The firm has a market capitalization of $67,850.00, a P/E ratio of 18.92, a P/E/G ratio of 1.16 and a beta of 1.18.
Walgreens Boots Alliance announced that its Board of Directors has approved a stock repurchase plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s management believes its shares are undervalued.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.34%. The ex-dividend date of this dividend is Wednesday, February 14th. Walgreens Boots Alliance’s payout ratio is currently 44.20%.
In other Walgreens Boots Alliance news, insider Stefano Pessina acquired 98,858 shares of the company’s stock in a transaction on Monday, January 15th. The shares were bought at an average cost of $76.07 per share, with a total value of $7,520,128.06. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 14.80% of the stock is currently owned by company insiders.
WBA has been the subject of a number of research analyst reports. Deutsche Bank initiated coverage on Walgreens Boots Alliance in a research note on Monday, December 4th. They issued a “hold” rating and a $78.00 price target for the company. Leerink Swann cut Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 1st. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 price objective for the company in a research note on Wednesday. Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Thursday, October 26th. Finally, Pivotal Research reduced their price objective on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating for the company in a research note on Tuesday, October 24th. Ten research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $85.05.
ILLEGAL ACTIVITY NOTICE: This article was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.chaffeybreeze.com/2018/02/15/whittier-trust-co-sells-702-shares-of-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.